J&J's Patent Suit Against Boston Scientific Heads To Jury

Law360, New York (June 21, 2005, 12:00 AM EDT) -- Johnson & Johnson’s closely watched patent infringement lawsuit against rival Boston Scientific Corp. over drug-coated stents has gone to the jury following closing arguments on Monday.

In closing arguments, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson’s groundbreaking invention of stenting technology “revolutionized cardiology.”

Diskant claimed Boston Scientific sought a “free ride” on his client's stent innovations by using the technology without permission since 1995.

“You have to pay for the ideas you take,”Diskant said.

Kirkland & Ellis partner John Desmarais, who...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.